Author

M. Seshadri

h-index 5 View on Semantic Scholar

We have 2 of 25 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

#small language model Open access Oct 2026

Real-World Treatment Patterns and Outcomes of Zanubrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma at University of California Academic Health Centers: A Retrospective Cohort Study.

Fatigue, bruising, and rash were significantly more common in the zanubrutinib cohort, and headache was significantly more common in the acalabrutinib cohort, and trends favored zanubrutinib for both measures.

A. Ayati, Kanika Chandra, Xiao-Liang Wang et al. · Oncology and Therapy · 0 citations

Open access Sep 2026

Immune Profiling after treatment with an Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Treatment-Refractory Progressive Multiple Sclerosis

Low dose anti CD19 CAR T cell therapy was safe, penetrated the CSF effectively, reduced intrathecal humoral activity, modulated peripheral immune tone, and appeared to stabilize EDSS scores, which support the continued investigation of CAR T cell therapy in MS.

S. Gupta, M. Seshadri, R. Dandekar et al. · medRxiv · 0 citations